Translating academic research into guidance to support healthcare improvement: how should guidance development be reported?


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
27 Dec 2019
Historique:
received: 10 09 2019
accepted: 29 11 2019
entrez: 29 12 2019
pubmed: 29 12 2019
medline: 31 3 2020
Statut: epublish

Résumé

There is interest internationally in improving the uptake of research evidence to inform health care quality and safety. This article focusses on guidance development from research studies as one method for improving research uptake. While we recognise that implementation strategies on the ´demand´ side for encouraging the uptake of research are important, e.g. knowledge brokers and university-practice collaborations, this article focusses on the ´production´ aspect of how guidance development is reported and the consequent influence this may have on end-users´ receptivity to evidence, in addition to other demand-side processes. The article considers the following question: how is guidance developed and what are the implications for reporting? We address this question by reviewing examples of guidance development reporting from applied health research studies, then describe how we produced guidance for a national study of evidence use in decision-making on adopting innovations. The starting point for reflecting on our experiences is a vignette of the guidance ´launch´ event at a national conference. Implications for reporting guidance development and supporting improvement are discussed. These include the need to (a) produce reporting standards for the production of guidance to match reporting standards for other research methods, (b) acknowledge the ´informal´ or emergent aspects of producing guidance and its role within a wider knowledge mobilization strategy, (c) consider guidance development from projects as part of a wider knowledge mobilization strategy, and (d) encourage a receptive environment for guidance development and use, including researcher training, durable funding to support impact, and closer relations between research and practice.

Sections du résumé

BACKGROUND BACKGROUND
There is interest internationally in improving the uptake of research evidence to inform health care quality and safety. This article focusses on guidance development from research studies as one method for improving research uptake. While we recognise that implementation strategies on the ´demand´ side for encouraging the uptake of research are important, e.g. knowledge brokers and university-practice collaborations, this article focusses on the ´production´ aspect of how guidance development is reported and the consequent influence this may have on end-users´ receptivity to evidence, in addition to other demand-side processes.
MAIN TEXT METHODS
The article considers the following question: how is guidance developed and what are the implications for reporting? We address this question by reviewing examples of guidance development reporting from applied health research studies, then describe how we produced guidance for a national study of evidence use in decision-making on adopting innovations. The starting point for reflecting on our experiences is a vignette of the guidance ´launch´ event at a national conference.
CONCLUSIONS CONCLUSIONS
Implications for reporting guidance development and supporting improvement are discussed. These include the need to (a) produce reporting standards for the production of guidance to match reporting standards for other research methods, (b) acknowledge the ´informal´ or emergent aspects of producing guidance and its role within a wider knowledge mobilization strategy, (c) consider guidance development from projects as part of a wider knowledge mobilization strategy, and (d) encourage a receptive environment for guidance development and use, including researcher training, durable funding to support impact, and closer relations between research and practice.

Identifiants

pubmed: 31881964
doi: 10.1186/s12913-019-4792-8
pii: 10.1186/s12913-019-4792-8
pmc: PMC6935180
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1000

Références

BMJ Qual Saf. 2016 Dec;25(12):986-992
pubmed: 26369893
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
BMC Health Serv Res. 2014 Jan 03;14:2
pubmed: 24383766
Health Technol Assess. 2001;5(23):iii-157
pubmed: 11785749
Implement Sci. 2016 Apr 05;11:48
pubmed: 27044391
Implement Sci. 2010 Nov 23;5:92
pubmed: 21092283
J R Soc Med. 2011 Dec;104(12):510-20
pubmed: 22179294
Implement Sci. 2017 Dec 04;12(1):145
pubmed: 29202772
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Health Serv Res Policy. 2017 Oct;22(4):243-249
pubmed: 28786700
BMJ Qual Saf. 2017 Jan;26(1):70-80
pubmed: 27129492
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Milbank Q. 2003;81(2):221-48, 171-2
pubmed: 12841049
Soc Sci Med. 2014 Jul;113:169-76
pubmed: 24880659
Int J Qual Health Care. 2019 Jun 12;:null
pubmed: 31187862
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000963
pubmed: 30775018
Health Technol Assess. 2017 Dec;21(76):1-292
pubmed: 29265004
BMC Public Health. 2012 Feb 09;12:109
pubmed: 22316003
PLoS Med. 2012;9(3):e1001185
pubmed: 22412356

Auteurs

Simon Turner (S)

School of Management, University of Los Andes, Edificio Santo Domingo, Cl. 21 #1 20, Bogotá, Colombia. s.turner@uniandes.edu.co.

Charlotte A Sharp (CA)

Centre for Primary Care and Health Services Research, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Jessica Sheringham (J)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK.

Shaun Leamon (S)

The Health Foundation, 8 Salisbury Square, London, EC4Y 8AP, UK.

Naomi J Fulop (NJ)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH